Luminal breast cancers represent approximately 75% of cases. these markers and resemble cells going through epithelial-mesenchymal changeover (EMT) [1]. These molecular subtypes differ in incidence survival and response to therapies significantly. More than 70% of breasts cancers fall in to the two luminal classes. They have a tendency to react to ‘endocrine’ therapies that focus… Continue reading Luminal breast cancers represent approximately 75% of cases. these markers and